Guardant Health, Inc. (GH)

NASDAQ: GH · USD

$182

+4.40 (+2.5%)· Recorded snapshot

Market cap	24.5B
Revenue (ttm)	1.2B
Net income (ttm)	-453.4M
EPS (ttm)	-$3.50
Shares out	134.2M
Volume	1,960,860
Beta	1.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): -453.4M
EPS (ttm): -$3.50
Market cap: 24.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-23.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GH indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001576280
Company name	Guardant Health, Inc.
Country	United States
Country code	US
CUSIP number	40131M109
Earnings date	2026-11-05
Earnings time	amc
Employees	2,506
Employees change	485
Employees growth	24%
Enterprise value	$25.1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Diagnostics & Research
IPO date	2018-10-04
Is primary listing	Yes
Is SPAC	No
ISIN number	US40131M1099
Last 10-K release date	2026-02-19
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$24.5B
Market cap category	Large-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$182.46
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	GH
U.S. state	California
Website	https://guardanthealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.92%
EV/Sales	21.56x
FCF / EV yield	-0.94%
FCF yield	-0.97%
Forward EV/Sales	16.48x
Forward P/S	16.06x
Industry forward P/E	30.87x
Industry P/E	50.24x
P/S ratio	21.01x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-39.64%
EBITDA margin	-36.39%
Gross margin	65.01%
Operating margin	-39.64%
Pretax margin	-38.41%
Profit margin	-38.33%
Profit per employee	$-180,940
Revenue per employee	$472,109
ROA	-18.07%
ROA (5Y)	-15.9%
ROCE	-29.81%
ROIC	-23.43%
SBC / revenue	16.17%
Tax / revenue	-0.09%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	47.68%
Gross profit growth (Q)	45.16%
Gross profit growth 3Y	34.57%
Gross profit growth 5Y	28.99%
Net income growth years	3
Revenue growth	42.74%
Revenue growth (Q)	44.33%
Revenue growth (QoQ)	11.04%
Revenue growth 3Y	32.36%
Revenue growth 5Y	29.6%
Revenue growth quarters	32
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-55.5M
Depreciation and amortization	$38.5M
EBIT	$-469M
EBITDA	$-430.6M
EPS	$-3.50
FCF per share	$-1.79
Financing cash flow	$737.8M
Free cash flow	$-240.7M
Free cash flow minus SBC	$-432.1M
Gross profit	$769.2M
Income taxes	$-1M
Investing cash flow	$-118.5M
Net borrowing	$402.5M
Net cash flow	$432.3M
Net income	$-453.4M
Operating cash flow minus SBC	$-376.5M
Operating income	$-469M
Revenue	$1.2B
Stock-based compensation	$191.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.28
Book value per share	$-1.67
Goodwill	$77.3M
Interest coverage	-97.39
Long-term assets	$547.7M
Long-term liabilities	$1.8B
Net cash (debt)	$-643.5M
Net cash / market cap	-2.59%
Piotroski F-Score	4
Property, plant and equipment	$302.9M
Shareholders' equity	$-222.9M
Tangible book value	$-325.4M
Tangible book value per share	$-2.44
Total assets	$1.9B
Total cash	$1.1B
Total debt	$1.7B
Total liabilities	$2.1B
WACC	12.14%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.73
Current assets	$1.4B
Current liabilities	$339M
Current ratio	4.03
Inventory turnover	4.37
Net working capital	$-34,000
Quick ratio	3.53
Working capital	$1B
Working capital turnover	1.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.62%
Dividend yield	0%
Shareholder yield	-4.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$139.53
1D price change	2.47%
1M price change	2.94%
1M total return	2.94%
1W price change	9.48%
1W total return	9.48%
1Y price change	157.53%
1Y return CAGR	157.7%
1Y total return	157.53%
20-day SMA	$168.85
200-day SMA	$129.75
3M price change	25.43%
3M total return	25.43%
3Y price change	631.01%
3Y return CAGR	94.05%
3Y total return	631.01%
50-day SMA	$169.05
50-day SMA vs 200-day SMA	50over200
52-week high	$191.05
52-week high date	2026-10-06
52-week low	$68.02
52-week low date	2025-10-29
5Y price change	62.5%
5Y return CAGR	10.2%
5Y total return	62.5%
6M price change	106.17%
6M total return	106.17%
All-time high	$191.05
All-time high date	2026-10-06
All-time low	$15.81
All-time low date	2024-04-19
Average true range (ATR)	$8.38
Average volume	1.8M
Beta (1Y)	0.91
Beta (2Y)	1.31
Beta (5Y)	1.58
Change from 52-week high	-4.5%
Change from 52-week low	168.25%
Change from all-time high	-4.5%
Change from all-time low	1,054.08%
Change from open	2.68%
Day's gap	-0.2%
Dollar volume	$357.8M
High price	$186.00
Low price	$177.00
Monthly RSI	77.07
Open price	$177.70
Position in 52-week range	60.67%
Premarket change	0.08%
Premarket close	$178.06
Premarket price	$178.20
Premarket volume	7.6K
Previous close	$178.06
Price vs 150-day SMA	30.77%
Price vs 20-day SMA	8.06%
Price vs 200-day SMA	40.62%
Price vs 50-day SMA	7.93%
Relative volume	1.09
RSI	62.7
Sharpe ratio	1.83
Sharpe ratio (3Y)	1.29
Sharpe ratio (5Y)	0.44
Sortino ratio	3.49
Sortino ratio (3Y)	2.3
Sortino ratio (5Y)	0.76
Volume	2M
Weekly RSI	65.42
YTD price change	78.64%
YTD total return	78.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	129.5M
Float percentage	96.48%
Shares change (QoQ)	1.21%
Shares change (YoY)	4.62%
Shares held by insiders	3.47%
Shares held by institutions	100.97%
Shares outstanding	134.2M
Short % of float	9.2%
Short % of shares	8.88%
Short ratio	6.5 days

Deeper analysis on GH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Frequently asked questions

About this GH report

Is a complete GH research report available?

No complete published report is available for Guardant Health, Inc. (GH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Guardant Health, Inc. (GH)

Price

Financial snapshot

Fair-value bridge

Latest news · GH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GH

Frequently asked questions